The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday.
The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy.
“It’s the first innovation in PTSD treatment in more than two decades. And it’s significant because I think it will also open up other innovation,” said Amy Emerson, CEO of MAPS Public Benefit Corporation, the research sponsor.
Just to add to your point: in PTSD your brain will prioritize certain synapses over others that may help you survive through the trauma, but will result in a continued focus on the trauma after the event has passed. So those ~500 synapses in depressive PTSD aren’t just lower than a healthy brain, but they’re also the wrong synapses for your current situation. Psychedelics can help you develop new synapses that are more relevant to your current life. As someone who experienced this therapy, it’s amazing how quickly it can happen, too. It’s a total game changer and should be available to anyone who wants to try it.